Shristi Shrestha, MD is a family physician who was raised in Kathmandu, Nepal
The hero ingredient in these products is called palmitoyl tetrapeptide-20 amide, and a few small studies have found it to be promising
Unexpected rapid weight loss (more than 23 pounds per week consistently) warrants a check-in with your care provider, as it may suggest underlying illness, excessive calorie restriction, or individual hypersensitivity
Novo responded the same day, publicly characterizing the product as "illegal mass compounding that poses a significant risk to patient safety." On February 6, the FDA announced it would take action against companies mass-marketing unapproved compounded GLP-1 products, and HHS General Counsel stated publicly that the department had referred Hims to the DOJ for potential FDCA violations
Our platform is designed to make personalized, medically supervised care attainable, which is especially important when dealing with the potential GI side effects of weight loss medications